May 15, 2017
Researchers quantify risks associated with common MS drug
Dr. Helen Tremlett, Canada Research Chair in Neuroepidemiology and Multiple Sclerosis, and her research...
Dr. Helen Tremlett, Canada Research Chair in Neuroepidemiology and Multiple Sclerosis, and her research...
New research from Dr. Catharine Winstanley’s lab confirms for the first time that even...
Working with a shared voice can be very effective for improving outcomes in the...
An international collaboration to address the economic costs of mental illness in member nations...
New research from Dr. Helen Tremlett, Canada Research Chair in Neuroepidemiology and Multiple Sclerosis...
Less than a year after publishing research identifying a single genetic mutation that caused...
As information-sharing has become decentralized in our digital age, are traditional approaches to science...
By the time a person with Parkinson’s disease (PD) receives a diagnosis, they have...
Almost half the cells and just one per cent of the unique genes found...
A growing field of research is examining the brain patterns produced by people with...
A simple compound is showing promise in limiting disease progression in multiple sclerosis (MS),...
The members of the Scientific Expert Working Group on Multiple Sclerosis and Chronic Cerebrospinal...